KRYS Stock Performance and Key Statistics

KRYS has a current P/E ratio of 39.34

The KRYS stock has a trailing twelve month price-to sales (P/S) ratio of 21.77 while its price-to-book (P/B) value is 7.07.

KRYS's price-to-free-cashflow (P/FCF) ratio is 37.21, an indicator that is currently being trending upward.

Based on KRYS's recent bid, its distance from 20 days simple moving average is 0.89%. It is 3.85% apart from 50 days simple moving average, and it is 45.69% apart from 200 days simple moving average.

The 52-week high for KRYS is $382.54 which is -7.36% away from the current price level whereas the distance of that from the 52-week low of $132.31 stands at 125.05%.

The performance of KRYS stock was not encouraging with most of its significant price indicators in green. Krystal Biotech, Inc.(NASDAQ: KRYS) shares have moved downward -0.95% or - $3.09 in the latest trading session and have gained 11.47% year-to-date (YTD). The stock has gained nearly 89.77% over the past year. After moving 44.46% over the trailing 3-month period, the stock is 85.57% higher in the 6-month period. Looking at its performance over the shorter term, it'sgained 0.98% a week and 16.54% a month.

The current 14-day RSI for KRYS stock is 53.32. Investors and traders alike rely on the relative strength index, or RSI, as an oscillating indicator. In terms of values, the RSI operates within a range ranging from 0 to 100. A rising RSI line indicates strength in the shares. As the RSI line falls, the opposite occurs. It is possible to examine different time periods when using the RSI indicator. Shorter time frames can cause the RSI to be more volatile. Most traders pay close attention to the marks between 30 and 70 on the RSI scale. When the stock price moves over 70, it is often considered to be an indicator of overbought conditions. Dropping below 30 indicates oversold territory. These levels are often used by traders to forecast stock price reversals.

ATR stands for Average True Range, which may be useful when traders or investors are assessing technical inventory. Currently, Krystal Biotech, Inc. (KRYS) has a 14-day ATR of 12.15.

After closing at $325.78 with 29.48M of its shares outstanding, the current enterprise value of KRYS is roughly 4.15B.

Krystal Biotech, Inc. (NASDAQ: KRYS) is up 89.77% when it comes to the percentage price change over the past 52-weeks. The percentage price change came more than that of broader S&P 500 index that came at a rise of 4.18%. KRYS stock price is also up 11.47% on its value in year-to-date trading.

The number outstanding shares of KRYS is 29.48M, and of these 79.4% shares are freely available for trading. On average, KRYS stock has traded 544.39K shares per day for the past 10 days. A total of 206.26K shares changed hands during the last trading session with the average session volume of 438.59K shares.